Correction to: Molecular Psychiatry advance online publication 29 March 2016; doi:10.1038/mp.2016.30
Following publication of this paper, the authors noticed that the affiliations for M Giustetto, C Vicidomini, C Sala and C Verpelli were incorrect. The correct affiliations appear below:
C Vicidomini1,2, L Ponzoni, D Lim, MJ Schmeisser, D Reim, N Morello, D Orellana, A Tozzi, V Durante, P Scalmani, M Mantegazza, AA Genazzani, M Giustetto3, M Sala, P Calabresi, TM Boeckers, C Sala1,2 and C Verpelli1,2
1CNR Neuroscience Institute, Milan, Italy;
2BIOMETRA University of Milan, Milan, Italy;
3Department of Neuroscience, University of Turin, Turin, Italy;
Additional information
The online version of the original article can be found at 10.1038/mp.2016.30
Rights and permissions
About this article
Cite this article
Vicidomini, C., Ponzoni, L., Lim, D. et al. Erratum: Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Mol Psychiatry 22, 784 (2017). https://doi.org/10.1038/mp.2016.70
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2016.70
This article is cited by
-
Downregulation of mGluR1-mediated signaling underlying autistic-like core symptoms in Shank1 P1812L-knock-in mice
Translational Psychiatry (2023)
-
An IGFBP2-derived peptide promotes neuroplasticity and rescues deficits in a mouse model of Phelan-McDermid syndrome
Molecular Psychiatry (2023)
-
A recurrent SHANK1 mutation implicated in autism spectrum disorder causes autistic-like core behaviors in mice via downregulation of mGluR1-IP3R1-calcium signaling
Molecular Psychiatry (2022)
-
Abnormalities of synaptic mitochondria in autism spectrum disorder and related neurodevelopmental disorders
Journal of Molecular Medicine (2021)
-
Lrrc7 mutant mice model developmental emotional dysregulation that can be alleviated by mGluR5 allosteric modulation
Translational Psychiatry (2019)